Sinn HP - Search Results

1

Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.

Beckhove P, Schütz F, Diel IJ, Solomayer EF, Bastert G, Foerster J, Feuerer M, Bai L, Sinn HP, Umansky V, Schirrmacher V. Beckhove P, et al. Among authors: sinn hp. Int J Cancer. 2003 Jul 1;105(4):444-53. doi: 10.1002/ijc.11125. Int J Cancer. 2003. PMID: 12712433

2

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.

Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H. Dall P, et al. Among authors: sinn hp. Int J Cancer. 1995 Feb 8;60(4):471-7. doi: 10.1002/ijc.2910600408. Int J Cancer. 1995. PMID: 7530237

3

Metastatic potential of small and minimally invasive breast carcinomas.

Sinn HP, Oelmann A, Anton HW, Diel IJ. Sinn HP, et al. Virchows Arch. 1994;425(3):237-41. doi: 10.1007/BF00196145. Virchows Arch. 1994. PMID: 7812508

4

[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].

Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF. Sinn HP, et al. Geburtshilfe Frauenheilkd. 1994 Oct;54(10):552-8. doi: 10.1055/s-2007-1022338. Geburtshilfe Frauenheilkd. 1994. PMID: 8001751 German.

5

Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.

Sinn HP, Heider KH, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P, Ponta H. Sinn HP, et al. Breast Cancer Res Treat. 1995;36(3):307-313. doi: 10.1007/BF00713402. Breast Cancer Res Treat. 1995. PMID: 8573713

6

[DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis].

Sinn HP, Haag D, Ehemann V, Magener A, Goerttler K, Bastert G, Otto HF. Sinn HP, et al. Pathologe. 1997 Jan;18(1):19-26. doi: 10.1007/s002920050192. Pathologe. 1997. PMID: 9157400 Review. German.

7

[Subtyping and prognostic assessment of invasive lobular breast carcinoma].

Sinn HP, Kellerhoff NM, Kellerhoff R, Bastert G, Otto HF. Sinn HP, et al. Pathologe. 1997 Jan;18(1):37-44. doi: 10.1007/s002920050194. Pathologe. 1997. PMID: 9157403 German.

8

[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support].

Solomayer EF, Diel IJ, Meyberg G, Sinn HP, Emig R, Wallwiener D, Bastert G. Solomayer EF, et al. Among authors: sinn hp. Zentralbl Gynakol. 1998;120(7):337-40. Zentralbl Gynakol. 1998. PMID: 9703656 German.

9

Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy.

Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF. Sinn HP, et al. Eur J Cancer. 1998 Apr;34(5):646-53. doi: 10.1016/s0959-8049(97)10106-x. Eur J Cancer. 1998. PMID: 9713268

10

Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.

Seute A, Sinn HP, Schlenk RF, Emig R, Wallwiener D, Grischke EM, Hohaus S, Döhner H, Haas R, Bentz M. Seute A, et al. Among authors: sinn hp. Int J Cancer. 2001 Jul 1;93(1):80-4. doi: 10.1002/ijc.1296. Int J Cancer. 2001. PMID: 11391625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters